ACADIA Pharmaceuticals Inc (ACAD)
Number of days of payables
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Payables turnover | — | — | — | — | — | |
Number of days of payables | days | — | — | — | — | — |
December 31, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ —
= —
The data provided for ACADIA Pharmaceuticals Inc shows that the number of days of payables is not available for the years ending on December 31, 2020, 2021, 2022, 2023, and 2024. This lack of information hinders a detailed analysis and assessment of the company's payment practices and its ability to manage its payables effectively over the specified periods. In order to perform a more comprehensive analysis of the financial health and efficiency of ACADIA Pharmaceuticals Inc, it would be beneficial to obtain the specific data for the number of days of payables in the future.
Peer comparison
Dec 31, 2024
Company name
Symbol
Number of days of payables
ACADIA Pharmaceuticals Inc
ACAD
—
Abbott Laboratories
ABT
—
AbbVie Inc
ABBV
—
Alkermes Plc
ALKS
18.68
Amphastar P
AMPH
31.10
ANI Pharmaceuticals Inc
ANIP
—
Arcus Biosciences Inc
RCUS
43.80
Biomarin Pharmaceutical Inc
BMRN
—
Bristol-Myers Squibb Company
BMY
41.38
Catalyst Pharmaceuticals Inc
CPRX
24.74
Collegium Pharmaceutical Inc
COLL
7.94